Moderna second bivalent COVID booster authorized in Canada
Maddie Meyer/Getty Images News                 

Health Canada has authorized Moderna's (NASDAQ:MRNA) second Omicron-targeted COVID-19 vaccine booster.
This booster targets the original SARS-CoV-2 virus strain, as well as the BA.4 and BA.5 Omicron subvariants.
The Canadian regulator had previously authorized a Moderna (MRNA) booster containing the original strain and the BA.1 Omicron subvariant in September.
Read Seeking Alpha contributor William Meyers' argument for why Moderna (MRNA) shares are currently priced attractively.